NDC 59651-275 – Roflumilast
Roflumilast 500 ug/1 · Tablet · Oral
Product NDC59651-275
Product details
- Brand name
- Roflumilast
- Generic name
- Roflumilast
- Labeler
- Aurobindo Pharma Limited
- Dosage form
- Tablet
- Route
- Oral
- Marketing category
- ANDA · ANDA213298
- Marketed since
- April 17, 2023
- Listing expires
- December 31, 2026
- Pharmacologic class
- Phosphodiesterase 4 Inhibitor
Active ingredients
- Roflumilast 500 ug/1
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 59651-275-30 | 30 TABLET in 1 BOTTLE (59651-275-30) | Apr 17, 2023 |
| 59651-275-90 | 90 TABLET in 1 BOTTLE (59651-275-90) | Apr 17, 2023 |
Other Roflumilast products
- 60687-786 Roflumilast 500 ug/1 · Tablet · American Health Packaging
- 69292-631 Roflumilast 500 ug/1 · Tablet · Amici Pharma Inc.
- 69292-630 Roflumilast 250 ug/1 · Tablet · Amici Pharma Inc.
- 67877-730 Roflumilast 250 ug/1 · Tablet · Ascend Laboratories, LLC
- 67877-480 Roflumilast 500 ug/1 · Tablet · Ascend Laboratories, LLC
- 59651-801 Roflumilast 250 ug/1 · Tablet · Aurobindo Pharma Limited
- 73190-086 Roflumilast 250 ug/1 · Tablet · AvKARE
- 73190-087 Roflumilast 500 ug/1 · Tablet · AvKARE
- 72162-2385 Roflumilast 500 ug/1 · Tablet · Bryant Ranch Prepack
- 31722-623 Roflumilast 500 ug/1 · Tablet · Camber Pharmaceuticals, Inc.
- 31722-676 Roflumilast 250 ug/1 · Tablet · Camber Pharmaceuticals, Inc.
- 51407-975 Roflumilast 500 ug/1 · Tablet · Golden State Medical Supply, Inc.